Trandolapril
NDC 65862-166, Trandolapril, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 65862-166
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078438
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-166 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANDOLAPRIL4 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-166-01 | 65862016601 | 100 TABLET in 1 BOTTLE (65862-166-01) |
| 65862-166-99 | 65862016699 | 1000 TABLET in 1 BOTTLE (65862-166-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f25ed16-e5e9-4170-b4b4-3b460887779e
Use it
Look up 65862-166 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-166 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-166. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.